RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Marketable securities, non-current

AbbVie Inc.ABBV

Market cap
$405.4B
P/E ratio
SummaryFinancials
Period EndMarketable securities, non-current (Million USD)YoY (%)
Dec 31, 2024279-8.22%
Dec 31, 2023304+26.14%
Dec 31, 2022241-13.00%
Dec 31, 2021277-5.46%
Dec 31, 2020293+215.05%
Dec 31, 201993-93.45%
Dec 31, 20181,420-32.06%
Dec 31, 20172,090+17.22%
Dec 31, 20161,783+1129.66%
Dec 31, 2015145+57.61%
Dec 31, 201492-22.03%
Dec 31, 2013118

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)